Gene Security Network, Inc. (GSN) announced today the introduction of the All Chromosome Aneuploidy Screening test, powered by Parental Support™bioinformatics. This is the first commercially available test to leverage bioinformatics to inform in vitro fertilization (IVF) transfer decisions by identifying potential abnormalities across all 24 chromosomes (aneuploidy) from a single embryonic cell. Test results are […]

Arbor Vita Corporation (AVC), a privately held biopharmaceutical company, today announced a strategic collaboration in women’s health with BD (Becton, Dickinson and Company), a leading global medical technology company. The collaboration and license agreement is initially focused on the development of a commercial diagnostic for cervical cancer, which globally affects more than 500,000 women each […]

QIAGEN N.V. (NASDAQ: QGEN) (FRANKFURT: QIA) today announced the launch of a new test to determine mutations of the K-ras gene. The K-ras gene is mutated in between 35 percent and 45 percent of metastatic colorectal cancer (CRC) patients. Studies have shown that K-ras testing can better define which CRC patients will benefit from treatment […]

Signature Genomic Laboratories announced it has made its Genoglyphix® microarray visualization program available to its full-service clients. Previously available only to laboratories that analyze microarray results using Signature research-use-only microarrays in-house, the HIPAA-compliant Genoglyphix service allows users to visualize microarray test results for their patients over a secure online server. For each patient, the Genoglyphix […]

BURLINGTON, N.C.–Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announces that it will be the first national clinical laboratory to offer HBV PCR testing using a newly FDA approved assay, the Roche COBAS® TaqMan® HBV Test. This assay, to be offered next week, is intended to be used as an aid in managing patients with […]